Compare Oxford Lane Capital Corp (OXLC) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oxford Lane Capital Corp vs Zoetis Inc — how do they compare? Oxford Lane Capital Corp trades at $8.85 (market cap $861.22M), while Zoetis Inc trades at $74.43 (market cap $31.59B). The key difference: Zoetis Inc is far larger — about 36.7× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays the higher dividend (27.21%). Which is the better fit depends on your goals.
| OXLC | ZTS | |
|---|---|---|
Market Cap | $861.22M | $31.59B |
Sector | Financials | Health |
52-Week High | $19.90 | $156.76 |
52-Week Low | $8.15 | $71.91 |
Dividend Yield | 27.21% | 2.81% |
Enterprise Value | — | $38.89B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OXLC trades at $8.87, up 1.14% today, but faces a bearish technical outlook with significant selling pressure. The company reported a net income of $48.46 million for 2025, but recent quarterly earnings have consistently missed expectations, including a substantial miss in Q1 2026. Despite a high dividend yield, financial performance shows strain with negative ROE and ROA, while cash flow is heavily dependent on financing activities.
The outlook is cautious due to deteriorating fundamentals, negative profitability metrics, and bearish analyst sentiment. The primary opportunity lies in the high dividend yield, but risks include unsustainable distributions, declining net asset value, and potential for further earnings volatility. Investor caution is warranted given the conflicting signals between dividend income and underlying financial health.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
